Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 23 (9), 2470-1

Concomitant Use of Pazopanib and Simvastatin Increases the Risk of Transaminase Elevations in Patients With Cancer

Concomitant Use of Pazopanib and Simvastatin Increases the Risk of Transaminase Elevations in Patients With Cancer

C F Xu et al. Ann Oncol.

Similar articles

See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback